179636-96-5

Basic information

• Product Name: 1-Pyrrolidinecarboxylic acid, 3-[[(phenylmethyl)amino]methyl]-, 1,1-dimethylethyl ester, (S)-
• CAS NO: 179636-96-5
• Molecular Formula: C17H26N2O2
• Molecular Weight: 290.406
• Mol File: 179636-96-5.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: 1-Pyrrolidinecarboxylic acid, 3-[[(phenylmethyl)amino]methyl]-, 1,1-dimethylethyl ester, (S)-(CAS DataBase Reference)
• NIST Chemistry Reference: 1-Pyrrolidinecarboxylic acid, 3-[[(phenylmethyl)amino]methyl]-, 1,1-dimethylethyl ester, (S)-(179636-96-5)
• EPA Substance Registry System: 1-Pyrrolidinecarboxylic acid, 3-[[(phenylmethyl)amino]methyl]-, 1,1-dimethylethyl ester, (S)-(179636-96-5)

Safety Data

• Hazardous Substances Data: 179636-96-5(Hazardous Substances Data)

Upstream product

• 132945-76-7 tert-butyl (3R)-3-cyano-1-pyrrolidinecarboxylate 
• 132945-75-6 (S)-tert-butyl 3-(methylsulfonyloxy)pyrrolidine-1-carboxylate 
• 101469-92-5 (S)-3-hydroxy-pyrrolidine-1-carboxylic acid tert-butyl ester 
• 24424-99-5 di-tert-butyl dicarbonate 
• 99735-47-4 (3R)-1-[(R)-1-phenylethyl]-3-(hydroxymethyl)pyrrolidine 
• 100-46-9 benzylamine 
• 177947-76-1 (3R)-1-(tert-butoxycarbonyl)-3-[(methane-sulfonyloxy)methyl]pyrrolidine 

Downstream Products

• 177947-80-7 (3S)-N(H)-3-<(N-benzylamino)methyl>pyrrolidine 
• 882868-71-5 Benzyl-(S)-1-pyrrolidin-3-ylmethyl-amine 
• 1426096-01-6 1,1-dimethylethyl (3S)-3-{[[(4-bromophenyl)carbonyl](phenylmethyl)amino]methyl}-1-pyrrolidinecarboxylate 
• 1426095-40-0 4-(1-benzofuran-5-yl)-N-{[(3R)-1-cyclopropylcarbonyl-3-pyrrolidinyl]methyl}-N-(phenylmethyl)benzamide 
• 1426095-41-1 4-(1H-benzimidazol-5-yl)-N-{[(3R)-1-cyclopropylcarbonyl-3-pyrrolidinyl]methyl}-N-(phenylmethyl)benzamide 
• 1426095-42-2 N-{[(3R)-1-cyclopropylcarbonyl-3-pyrrolidinyl]methyl}-4'-(methyloxy)-N-(phenylmethyl)-4-biphenylcarboxamide 
• 1426095-43-3 N-{[(3R)-1-cyclopropylcarbonyl-3-pyrrolidinyl]methyl}-4-(1H-indol-6-yl)-N-(phenylmethyl)benzamide 
• 1426095-44-4 N-{[(3R)-1-cyclopropylcarbonyl-3-pyrrolidinyl]methyl}-4-(1H-indol-4-yl)-N-(phenylmethyl)benzamide 
• 1426095-45-5 N-{[(3R)-1-cyclopropylcarbonyl-3-pyrrolidinyl]methyl}-4-(1H-indol-7-yl)-N-(phenylmethyl)benzamide 
• 1426095-46-6 3'-chloro-N-{[(3R)-1-cyclopropylcarbonyl-3-pyrrolidinyl]methyl}-4'-fluoro-N-(phenylmethyl)-4-biphenylcarboxamide 
• 1426096-03-8 4-bromo-N-(phenylmethyl)-N-[(3R)-3-pyrrolidinylmethyl]benzamide hydrochloride 
• 1426096-05-0 4-bromo-N-{[(3R)-1-cyclopropylcarbonyl-3-pyrrolidinyl]methyl}-N-(phenylmethyl)benzamide 
• 1426095-37-5 N-{[(3R)-1-cyclopropylcarbonyl-3-pyrrolidinyl]methyl}-4-(1H-indazol-5-yl)-N-(phenylmethyl)benzamide 
• 1426095-38-6 N-{[(3R)-1-cyclopropylcarbonyl-3-pyrrolidinyl]methyl}-4-(1H-indazol-6-yl)-N-(phenylmethyl)benzamide 

Relevant articles and documents

FATTY ACID SYNTHASE INHIBITORS

This invention relates to carboxamides and reverse carboxamides according to Formula (I) and the use of carboxamides and reverse carboxamides for the modulation, notably the inhibition of the activity or function of fatty acid synthase (FAS). Suitably, the present invention relates to the use of carboxamides and reverse carboxamides in the treatment of cancer.

3-[2-(Pyrrolidin-1-yl)ethyl]indoles and 3-[3-(Piperidin-1- yl)propyl]indoles: Agonists for the h5-HT(1D) receptor with high selectivity over the h5-HT(1B) subtype

-